MicroPort MedBot forecasts first half-year profit as Toumai overseas revenue grows
MicroPort MedBot issued a positive profit alert forecasting RMB28 million to RMB40 million in first-half profit, reversing a prior-year loss as revenue accelerated.
Evidence notes
- The company forecast first-half profit of roughly RMB28 million to RMB40 million versus a RMB115 million loss a year earlier.
- Expected revenue growth was approximately 200% to 230% year over year.
- MicroPort MedBot cited overseas Toumai surgical-robot revenue growth of more than 450%.
Company context
MicroPort MedBot is a Shanghai surgical-robotics company developing laparoscopic, orthopaedic, vascular-interventional and other robot-assisted procedure systems.